Sovaldi
Formulated for chronic hepatitis c to mitigate viral progression.
Strengths: 400mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Hepatitis C Antiviral
- Pharmacological class
NS5B Polymerase Inhibitor
- Contraindications
hypersensitivity to sofosbuvir
- Minor side effects
fatigue; headache
- Moderate side effects
nausea; insomnia
- Serious side effects
hypersensitivity — requires immediate medical attention
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
Formulated for chronic hepatitis c to mitigate viral progression.
- Prescription status
POM
- Manufacturer
Gilead Sciences
- Onset Time
1–2 weeks
- Duration
12–24 weeks
- Storage instructions
Store below 30°C in the original container.
- Drug interactions
amiodarone; rifampicin
- Age restrictions
For adult use.
Mechanism of action
An NS5B polymerase inhibitor that blocks the replication machinery of the hepatitis C virus, thereby reducing viral load.
Pregnancy and breastfeeding
Pregnancy: Consult a healthcare professional before use. Breastfeeding: Breastfeeding is not recommended during therapy.
Sovaldi
Formulated for chronic hepatitis c to mitigate viral progression.
Editorial Notes
- Active ingredient(s): Sofosbuvir
- Listed indication(s): Chronic Hepatitis C
Available option
- 28 tablets - 400 mg865-400-mg-6370